Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2024-09-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, including major shareholding notifications and changes in special relationships (e.g., board members, affiliates). This falls under the 'Major Shareholding Notification' category.
2024-09-04 Korean
합병등종료보고서(합병)
M&A Activity Classification · 100% confidence The document is a '합병등종료보고서' (Report on the Completion of Merger), which is a formal regulatory filing required by the Financial Supervisory Service (FSS) in South Korea upon the finalization of a merger process. It details the merger schedule, changes in shareholding, creditor protection procedures, and post-merger financial status. Since it is a specific regulatory filing regarding M&A completion and does not fit into the other categories like 'TAR' (which is typically for the initial announcement/proposal) or 'RPA' (which is for report publication notices), it is classified as a Regulatory Filing (RNS).
2024-09-04 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company (Creosg) detailing a decision to conduct a paid-in capital increase (유상증자결정). It outlines the number of new shares, the purpose of the funds, the issuance method (shareholder-priority public offering), and the timeline for subscription and payment. This falls under the category of share issuance and capital changes.
2024-09-03 Korean
증권신고서(지분증권) (2024.11)
Capital/Financing Update Classification · 100% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase (유상증자) for (주)크레오에스지, including information on the number of shares, total amount, and extensive risk factors (business, financial, and management risks). This document is a formal regulatory filing for a public offering of securities, which falls under the 'Capital/Financing Update' category.
2024-09-03 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director (Hwang Seon-guk) from the company CreoSG. This falls under the category of board and management changes.
2024-08-28 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 크레오에스지' (CreoSG Co., Ltd.) covering the period from January 1, 2024, to June 30, 2024. It contains comprehensive financial information, business descriptions, management analysis, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.